SOUTH SAN FRANCISCO, CA, USA I August 12, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...

Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a ...

Enzalutamide and other ARPIs are key in treating metastatic prostate cancer by blocking androgen receptors, improving patient ...

From taking HRT to eating a healthy diet, Kate Muir shares some of the precautionary measures she's trying to avoid ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

Explores Behemoth Labz GLP‑1 nasal formulation's structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic ...

On this episode of Ropes & Gray's ITC-focused podcast series, Talkin' Trade, IP litigators Matt Rizzolo, Matt Shapiro, and Lara Ameri break down ...

These days, the culture of drinking is more relaxed, commercialised, and often glamorised, the liver, is bearing the burden.

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

Phase 1 trial of TERN-701 in chronic myeloid leukemia (CML) enrolling well; efficacy and safety data including 6-month major molecular response (MMR) rates expected in 4Q25Phase 2 trial of TERN-601 ...